Right Ventricular Endomyocardial Biopsy in Undetermined Form of Chagas' Disease

Mady, Charles; Pereira-Barretto, Antonio Carlos; Ianni, Bárbara Maria; Lopes, Edgard Augusto; Pileggi, Fúlvio
December 1984
Angiology;Dec1984, Vol. 35 Issue 12, p755
Academic Journal
Right ventricular endomyocardial biopsy was carried out in thirty three patients with undetermined form of Chagas' disease. Fragments obtained by this method were analysed under light microscopy with hematoxilin-eosin, and Masson trichromic stains. Thirteen (39.4%) patients showed normal myocardial fragments and twenty patients (60.6%) had them altered. Alterations included fiber degeneration, volume changes, interstitial edema, inflammatory infiltrates and fibrosis. These data permit to conclude that only part of patients with this form of Chagas' disease have an incipient myocardial attack and that the alterations found in the fragments obtained are mild. The remaining patients would be either individuals with chagasic infection without cardiac disease or have spontaneous healing. This should be considered in the future treatment of the disease.


Related Articles

  • American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies. Miles, Michael A; Feliciangeli, M Dora; de Arias, Antonieta Rojas // BMJ: British Medical Journal (International Edition);6/28/2003, Vol. 326 Issue 7404, p1444 

    Evaluates American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies. Disease that is a parisitic infection that has far reaching consequences for public health and national economies in Latin America; Discussion of infection with Trypanosoma...

  • Trypanosomiasis Control, Democratic Republic of Congo, 1993-2003. Lutumba, Pascal; Robays, Jo; Mia Bilenge, Constantin Miaka; Ku Mesu, Victor Kande Betu; Molisho, Didier; Declercq, Johan; Van Der Veken, Wim; Meheus, Filip; Jannin, Jean; Boelaert, Marleen // Emerging Infectious Diseases;Sep2005, Vol. 11 Issue 9, p1382 

    In the Democratic Republic of Congo (DRC), human African trypanosomiasis (HAT) reached unprecedented levels in the 1990s, To assess recent trends and evaluate control efforts, we analyzed epidemiologic and financial data collected by all agencies involved in HAT control in DRC from 1993 to 2003-...

  • An exploratory GIS-based method to identify and characterise landscapes with an elevated epidemiological risk of Rhodesian human African trypanosomiasis. Wardrop, Nicola A.; FŠvre, Eric M.; Atkinson, Peter M.; Kakembo, Abbas S. L.; Welburn, Susan C. // BMC Infectious Diseases;2012, Vol. 12 Issue 1, p316 

    Background: Specific land cover types and activities have been correlated with Trypanosoma brucei rhodesiense distributions, indicating the importance of landscape for epidemiological risk. However, methods proposed to identify specific areas with elevated epidemiological risk (i.e. where...

  • Inhibition of Autoimmune Chagas-Like Heart Disease by Bone Marrow Transplantation. Guimaro, Maria C.; Alves, Rozeneide M.; Rose, Ester; Sousa, Alessandro O.; de Cássia Rosa, Ana; Hecht, Mariana M.; Sousa, Marcelo V.; Andrade, Rafael R.; Vital, Tamires; Plachy, Jiří; Nitz, Nadjar; Hejnar, Jiří; Gomes, Clever C.; L. Teixeira, Antonio R. // PLoS Neglected Tropical Diseases;Dec2014, Vol. 8 Issue 12, p1 

    Background: Infection with the protozoan Trypanosoma cruzi manifests in mammals as Chagas heart disease. The treatment available for chagasic cardiomyopathy is unsatisfactory. Methods/Principal Findings: To study the disease pathology and its inhibition, we employed a syngeneic chicken model...

  • CHAGAS' DISEASE, A POSSIBLE CAUSE OF MEGAESOPHAGUS AND MEGACOLON. Jung, Rodney C. // American Journal of Gastroenterology;Sep1959, Vol. 32 Issue 3, p311 

    Discusses evidence for the consideration of Chagas' disease as a possible cause of megaesophagus and megacolon in the U.S. Overview of previous studies on megaesophagus and megacolon; Types of megacolon; Background information on Chagas' disease.

  • Clinical Radiographic, and Manometric Evolution of Esophageal Involvement by Chagas' Disease. Meneghelli, Ulysses G.; Peria, Fernanda M.; Darezzo, Fabiana M. R.; Almeida, Fernando H.; Rodrigues, Carla M.; Aprile, Lilian R. O.; Dantas, Roberto O. // Dysphagia (0179051X);Winter2005, Vol. 20 Issue 1, p40 

    The complete manifestation of esophageal Chagas' disease includes nonperistaltic contractions in the esophageal body, absent lower esophageal sphincter (LES) relaxation, and dilatation of the organ. However, some patients have a minor degree of esophageal denervation and esophageal motility that...

  • The Challenges of Chagas Disease Grim Outlook or Glimmer of Hope. Tarleton, Rick L.; Reithinger, Richard; Urbina, Julio A.; Kitron, Uriel; Gürtler, Ricardo E. // PLoS Medicine;Dec2007, Vol. 4 Issue 12, pe332 

    The authors discuss the key challenges that undermine the control of Chagas disease and that must be urgently addressed to ensure long-term, sustainable control.

  • Silent epidemic.  // New Scientist;8/26/2006, Vol. 191 Issue 2566, p7 

    The article reports that two new studies on Chagas' disease that necessitates urgent measure by the U.S. government against this disease. The parasite Trypanosoma cruzi that causes this disease is carried by more than 10 million Latin Americans. The blood and organ donations in North America...

  • Drug company and charity agree to collaborate to develop a new treatment for Chagas' disease. Roehr, Bob // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/10/2009, Vol. 339 Issue 7725, p826 

    The article deals with the agreement reached by the Drugs for Neglected Diseases initiative (DNDi) with the Japanese company Eisai in October 2009 to develop to first compound to treat Chagas' disease. An endemic in Latin American and Caribbean countries, the disease is caused by the parasite...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics